PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9563900-0	1998	Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells.	Paclitaxel	66-71	interleukin 6	Homo sapiens	0-13	
9563900-6	1998	In the presence of IL-6, the DNA distribution pattern induced by Taxol or vinblastine was altered.	Paclitaxel	65-70	interleukin 6	Homo sapiens	19-23	
9563900-7	1998	Whereas IL-6 augmented the sub-G1 fraction and G2-M phase for Taxol-treated cells, only the G2-M phase was increased for vinblastine-treated cells.	Paclitaxel	62-67	interleukin 6	Homo sapiens	8-12	
9563900-11	1998	In the presence of IL-6, the number of cells containing microtubule asters increased for Taxol treatment, but not for vinblastine treatment.	Paclitaxel	89-94	interleukin 6	Homo sapiens	19-23	
9563900-12	1998	These data indicate that IL-6 leads to differential modulation of the cytotoxicity of Taxol and vinblastine in U266 cells.	Paclitaxel	86-91	interleukin 6	Homo sapiens	25-29	
9563900-14	1998	Furthermore, our data suggest that the microtubule-associated form of mitogen-activated protein kinase may play a role in IL-6-mediated enhancement of the cytotoxicity of Taxol.	Paclitaxel	171-176	interleukin 6	Homo sapiens	122-126